TY - JOUR
T1 - Developmental endothelial locus-1 modulates platelet-monocyte interactions and instant blood-mediated inflammatory reaction in islet transplantation
AU - Kourtzelis, Ioannis
AU - Kotlabova, Klara
AU - Lim, Jong-Hyung
AU - Mitroulis, Ioannis
AU - Ferreira, Anaisa
AU - Chen, Lan-Sun
AU - Gercken, Bettina
AU - Steffen, Anja
AU - Kemter, Elisabeth
AU - Klotzsche-von Ameln, Anne
AU - Waskow, Claudia
AU - Hosur, Kavita
AU - Chatzigeorgiou, Antonios
AU - Ludwig, Barbara
AU - Wolf, Eckhard
AU - Hajishengallis, George
AU - Chavakis, Triantafyllos
PY - 2016/4
Y1 - 2016/4
N2 - Platelet-monocyte interactions are strongly implicated in thrombo-inflammatory injury by actively contributing to intravascular inflammation, leukocyte recruitment to inflamed sites, and the amplification of the procoagulant response. Instant blood-mediated inflammatory reaction (IBMIR) represents thrombo-inflammatory injury elicited upon pancreatic islet transplantation (islet-Tx), thereby dramatically affecting transplant survival and function. Developmental endothelial locus-1 (Del-1) is a functionally versatile endothelial cell-derived homeostatic factor with anti-inflammatory properties, but its potential role in IBMIR has not been previously addressed. Here, we establish Del-1 as a novel inhibitor of IBMIR using a whole blood-islet model and a syngeneic murine transplantation model. Indeed, Del-1 pre-treatment of blood before addition of islets diminished coagulation activation and islet damage as assessed by C-peptide release. Consistently, intraportal islet-Tx in transgenic mice with endothelial cell-specific overexpression of Del-1 resulted in a marked decrease of monocytes and platelet-monocyte aggregates in the transplanted tissues, relative to those in wild-type recipients. Mechanistically, Del-1 decreased platelet-monocyte aggregate formation, by specifically blocking the interaction between monocyte Mac-1-integrin and platelet GPIb. Our findings reveal a hitherto unknown role of Del-1 in the regulation of platelet-monocyte interplay and the subsequent heterotypic aggregate formation in the context of IBMIR. Therefore, Del-1 may represent a novel approach to prevent or mitigate the adverse reactions mediated through thrombo-inflammatory pathways in islet-Tx and perhaps other inflammatory disorders involving platelet-leukocyte aggregate formation.
AB - Platelet-monocyte interactions are strongly implicated in thrombo-inflammatory injury by actively contributing to intravascular inflammation, leukocyte recruitment to inflamed sites, and the amplification of the procoagulant response. Instant blood-mediated inflammatory reaction (IBMIR) represents thrombo-inflammatory injury elicited upon pancreatic islet transplantation (islet-Tx), thereby dramatically affecting transplant survival and function. Developmental endothelial locus-1 (Del-1) is a functionally versatile endothelial cell-derived homeostatic factor with anti-inflammatory properties, but its potential role in IBMIR has not been previously addressed. Here, we establish Del-1 as a novel inhibitor of IBMIR using a whole blood-islet model and a syngeneic murine transplantation model. Indeed, Del-1 pre-treatment of blood before addition of islets diminished coagulation activation and islet damage as assessed by C-peptide release. Consistently, intraportal islet-Tx in transgenic mice with endothelial cell-specific overexpression of Del-1 resulted in a marked decrease of monocytes and platelet-monocyte aggregates in the transplanted tissues, relative to those in wild-type recipients. Mechanistically, Del-1 decreased platelet-monocyte aggregate formation, by specifically blocking the interaction between monocyte Mac-1-integrin and platelet GPIb. Our findings reveal a hitherto unknown role of Del-1 in the regulation of platelet-monocyte interplay and the subsequent heterotypic aggregate formation in the context of IBMIR. Therefore, Del-1 may represent a novel approach to prevent or mitigate the adverse reactions mediated through thrombo-inflammatory pathways in islet-Tx and perhaps other inflammatory disorders involving platelet-leukocyte aggregate formation.
KW - Animals
KW - Blood Coagulation/genetics
KW - Blood Platelets/physiology
KW - Carrier Proteins/genetics
KW - Cells, Cultured
KW - Humans
KW - Inflammation/genetics
KW - Islets of Langerhans/metabolism
KW - Islets of Langerhans Transplantation
KW - Macrophage-1 Antigen/metabolism
KW - Male
KW - Mice
KW - Mice, Inbred C57BL
KW - Mice, Transgenic
KW - Monocytes/physiology
KW - Platelet Aggregation/genetics
KW - Platelet Glycoprotein GPIb-IX Complex/metabolism
KW - Thrombosis/genetics
U2 - 10.1160/TH15-05-0429
DO - 10.1160/TH15-05-0429
M3 - Article
C2 - 26676803
SN - 0340-6245
VL - 115
SP - 781
EP - 788
JO - Thrombosis and haemostasis
JF - Thrombosis and haemostasis
IS - 4
ER -